These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7679701

  • 61. Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells.
    Liu L, Abken H, Pföhler C, Rappl G, Tilgen W, Reinhold U.
    Clin Exp Immunol; 2000 Jul; 121(1):94-9. PubMed ID: 10886244
    [Abstract] [Full Text] [Related]

  • 62. Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene.
    Schanberg LE, Fleenor DE, Kurtzberg J, Haynes BF, Kaufman RE.
    Proc Natl Acad Sci U S A; 1991 Jan 15; 88(2):603-7. PubMed ID: 1703303
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death.
    Rappl G, Abken H, Muche JM, Sterry W, Tilgen W, André S, Kaltner H, Ugurel S, Gabius HJ, Reinhold U.
    Leukemia; 2002 May 15; 16(5):840-5. PubMed ID: 11986945
    [Abstract] [Full Text] [Related]

  • 65. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma.
    Jakob T, Neuber K, Altenhoff J, Kowalzick L, Ring J.
    Acta Derm Venereol; 1996 Jan 15; 76(1):34-6. PubMed ID: 8721488
    [Abstract] [Full Text] [Related]

  • 66. Isolation and characterization of mouse CD7 cDNA.
    Yoshikawa K, Seto M, Ueda R, Obata Y, Fukatsu H, Segawa A, Takahashi T.
    Immunogenetics; 1993 Jan 15; 37(2):114-9. PubMed ID: 7678579
    [Abstract] [Full Text] [Related]

  • 67. CD7-positive Sézary syndrome with a Th1 cytokine profile.
    Yagi H, Tokura Y, Furukawa F, Takigawa M.
    J Am Acad Dermatol; 1996 Feb 15; 34(2 Pt 2):368-74. PubMed ID: 8655729
    [Abstract] [Full Text] [Related]

  • 68. Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain).
    Dummer R, Heald PW, Nestle FO, Ludwig E, Laine E, Hemmi S, Burg G.
    Blood; 1996 Aug 15; 88(4):1383-9. PubMed ID: 8695857
    [Abstract] [Full Text] [Related]

  • 69. Expression of V beta gene segments by Sezary cells.
    Gorochov G, Bachelez H, Cayuela JM, Legac E, Laroche L, Dubertret L, Sigaux F.
    J Invest Dermatol; 1995 Jul 15; 105(1):56-61. PubMed ID: 7542297
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Immunophenotypic identification of Sezary cells in peripheral blood.
    Bogen SA, Pelley D, Charif M, McCusker M, Koh H, Foss F, Garifallou M, Arkin C, Zucker-Franklin D.
    Am J Clin Pathol; 1996 Dec 15; 106(6):739-48. PubMed ID: 8980349
    [Abstract] [Full Text] [Related]

  • 72. Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis.
    Jensen AW, Hokland M, Jørgensen H, Justesen J, Ellegaard J, Hokland P.
    Blood; 1991 Sep 01; 78(5):1292-300. PubMed ID: 1715222
    [Abstract] [Full Text] [Related]

  • 73. Application of Blood Lymphocyte Immunophenotype and TCR Gene Rearrangement in the Diagnosis of CTCL.
    You R, Wang Y, Gong Y, Sun J, Lu Y, Miao L, Guo S, Qu C.
    Clin Lab; 2024 Feb 01; 70(2):. PubMed ID: 38345989
    [Abstract] [Full Text] [Related]

  • 74. Clinical relevance of immunological dissection in T-ALL: a report on 20 cases with stem cell (CD7+, CD4-, CD8-, CD1-) phenotype.
    Ferrara F, Cimino R, Antinolfi I, De Rosa C, Mele G, Mettivier V, Fusco C, Del Vecchio L.
    Am J Hematol; 1992 Jun 01; 40(2):98-102. PubMed ID: 1375001
    [Abstract] [Full Text] [Related]

  • 75. Molecular cloning of the gene coding for the human T cell differentiation antigen CD7.
    Yoshikawa K, Seto M, Ueda R, Obata Y, Notake K, Yokochi T, Takahashi T.
    Immunogenetics; 1991 Jun 01; 33(5-6):352-60. PubMed ID: 1711009
    [Abstract] [Full Text] [Related]

  • 76. CD7 expression in malignant pleural mesothelioma.
    Hibi S, Kataoka Y, Fujita N, Okabe H, Yoshikawa K, Seto M, Ueda R, Imashuku S.
    Jpn J Cancer Res; 1992 Jul 01; 83(7):680-3. PubMed ID: 1381341
    [Abstract] [Full Text] [Related]

  • 77. Clinical and biologic characteristics of CD7+ acute myeloid leukemia. Our experience and literature review.
    Shimamoto T, Ohyashiki JH, Ohyashiki K, Kawakubo K, Inatomi Y, Fujieda H, Nakazawa S, Kimura N, Miyauchi J, Toyama K.
    Cancer Genet Cytogenet; 1994 Mar 01; 73(1):69-74. PubMed ID: 7513604
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry.
    Ginaldi L, Matutes E, Farahat N, De Martinis M, Morilla R, Catovsky D.
    Br J Haematol; 1996 Jun 01; 93(4):921-7. PubMed ID: 8703826
    [Abstract] [Full Text] [Related]

  • 80. Spontaneous IL-8 production by CD4(+), CD7(+) leukemia cells in erythrodermic Sézary syndrome.
    Ogawa F, Shimizu K, Hamasakia Y, Tanaka Y, Katayama I, Yamada Y, Tomonaga M.
    Leuk Lymphoma; 2002 May 01; 43(5):1061-6. PubMed ID: 12148887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.